Analysis of IDH1 Mutation Spectrum from Non-Small-Cell Lung Cancer in East Asian Patients

被引：0
作者：
Wang, L. [1 ]
Xu, C. [2 ]
Wang, W. [3 ]
Zhang, Q. [2 ]
Zhuang, W. [2 ]
Zhu, Y. [4 ]
Huang, Z. [2 ]
Chen, G. [5 ]
Fang, M. [3 ]
Lv, T. [6 ]
Song, Y. [6 ]
机构：
[1] Baotou Canc Hosp, Baotou, Peoples R China
[2] Fujian Canc Hosp, Fuzhou, Fujian, Peoples R China
[3] Zhejiang Canc Hosp, Chemotherapy, Hangzhou, Zhejiang, Peoples R China
[4] Zhejiang Rongjun Hosp, Thorac Dis Ctr, Jiaxing, Peoples R China
[5] Fujian Canc Hosp, Pathol, Fuzhou, Fujian, Peoples R China
[6] Jinling Hosp, Nanjing, Jiangsu, Peoples R China
来源：
JOURNAL OF THORACIC ONCOLOGY | 2019年 / 14卷 / 10期
关键词：
non-small-cell lung cancer; IDH1; mutation; prognosis;
D O I：
10.1016/j.jtho.2019.08.2099
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EP1.03-18
引用
收藏
页码：S960 / S960
页数：1
相关论文
共 50 条
  • [41] EGFR point mutation confers resistance to gefitinib in a patient with non-small-cell lung cancer
    Giaccone, G
    NATURE CLINICAL PRACTICE ONCOLOGY, 2005, 2 (06): : 296 - 297
  • [42] AR Mutations Defines a Unique Molecular Class of Non-Small Cell Lung Cancer in East Asian Patients
    Xu, C.
    Wang, W.
    Wang, D.
    Zhu, Y.
    Zhuang, W.
    Fang, M.
    Lv, T.
    Song, Y.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S537 - S537
  • [43] The Clinical Significance of Serum MASP-2 and IDH1 in the Early Diagnosis of Non-Small Cell Lung Cancer
    Chen, Yan
    Wu, En-Dong
    Ma, Shang
    Bai, Wan-Qiu
    Yin, Yan-Jun
    Shi, Guang-Li
    CLINICAL LABORATORY, 2020, 66 (11) : 2287 - 2296
  • [44] Progress of non-small-cell lung cancer with ROS1 rearrangement
    Yang, Xin
    Tang, Zhe
    Li, Jing
    Jiang, Jizong
    Liu, Yue
    FRONTIERS IN MOLECULAR BIOSCIENCES, 2023, 10
  • [45] Somatic Mutation Analysis of RB1 Gene in Chinese Non-Small Cell Lung Cancer Patients
    Wang, W.
    Xu, C.
    Zhuang, W.
    Song, Z.
    Zhu, Y.
    Chen, R.
    Guan, Y.
    Yi, X.
    Fang, M.
    Lv, T.
    Song, Y.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S1941 - S1941
  • [46] Chemotherapy of elderly patients with non-small-cell lung cancer
    Kloke, O
    ZEITSCHRIFT FUR GERONTOLOGIE UND GERIATRIE, 2001, 34 (04): : 277 - 279
  • [47] Amrubicin for non-small-cell lung cancer and small-cell lung cancer
    Kurata, Takayasu
    Okamoto, Isamu
    Tamura, Kenji
    Fukuoka, Masahiro
    INVESTIGATIONAL NEW DRUGS, 2007, 25 (05) : 499 - 504
  • [48] Non-small cell lung cancers with isocitrate dehydrogenase 1 or 2 (IDH1/2) mutations
    Toth, Laura N.
    de Abreu, Francine B.
    Tafe, Laura J.
    HUMAN PATHOLOGY, 2018, 78 : 138 - 143
  • [49] EGFR mutation status in Tunisian non-small-cell lung cancer patients evaluated by mutation-specific immunohistochemistry
    Mraihi, Zohra
    Ben Amar, Jihen
    Bouacha, Hend
    Rammeh, Soumaya
    Hila, Lamia
    BMC PULMONARY MEDICINE, 2018, 18
  • [50] Amrubicin for non-small-cell lung cancer and small-cell lung cancer
    Takayasu Kurata
    Isamu Okamoto
    Kenji Tamura
    Masahiro Fukuoka
    Investigational New Drugs, 2007, 25 : 499 - 504
12345